Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Endocrinology Drugs Market to reach USD 45814.2 million by the end of 2030.

Global Endocrinology Drugs Market Size study & Forecast, by Therapy Area (Diabetes drugs, HGH, Thyroid hormone disorders, Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), and Regional Analysis, 2023-2030

Product Code: HLSDT-92447194
Publish Date: 19-06-2023
Page: 200

Global Endocrinology Drugs Market is valued at approximately USD 25084.24 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.82% over the forecast period 2023-2030. Endocrinology drugs deals with endocrine disorders, which are related to hormone imbalance and dysfunction in the endocrine system. Endocrinology drugs play an important role in providing therapeutic options for patients suffering from the endocrine disorder. The endocrinology drug market is being driven by factors such as Growing clinical trials of endocrinology drugs and rising endocrine disorders such as diabetes and thyroid.

Endocrinology drugs used to treat diabetes include insulin, which is a hormone that helps regulate blood sugar levels, and oral hypoglycemic agents (OHAs) such as metformin, sulfonylureas, and meglitinides. These drugs are designed to lower blood sugar levels and prevent complications associated with diabetes. According to the World health organization 537 million people lining with diabetes in 2021 and projections show this number is rising to 783 million people diabetic by 2045. Thus, rising in endocrine disorders fuels the market growth. In addition, advanced drug development and a growing aging population are creating a lucrative opportunity for market growth. However, Patent expiry on major endocrinology drugs is the major challenge impeding the endocrinology drugs market growth during the forecast years 2023-2030.

The key regions considered for the Global Endocrinology Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to high healthcare expenses and a high level of awareness in public, USA spends around 17.8% of the total GDP on healthcare. Where Asia Pacific is expected to have significant growth owing to factors such as rising disease prevalence, rising healthcare expenditure, a rapidly growing population and Government initiatives.

Major market player included in this report are:
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Hanmi Pharm Co. Ltd.
Oramed Pharmaceuticals Inc.
Pfizer Inc.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Biocon Ltd.
Ascendis Pharma AS
Endo International Plc
Recent Developments in the Market:
Ø On February 2022, Biocon announced the acquisition of Viatris’ biosimilar portfolio for USD 3.335 billion. This acquisition strengthened Biocon’s biosimilar product portfolio and improved its revenue generation.
Ø In Aug 2021, The U.S. Food and Drug Administration (FDA) approved an expanded label for Eli Lilly and Company’s rapid-acting Endocrinology Drugs, Lyumjev® (Endocrinology Drugs lispro-AABC injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous Endocrinology Drugs infusion (CSII) with an Endocrinology Drugs pump.
Ø In July 2021, Semglee, a first-of-its-kind Endocrinology Drugs product made by India’s Biocon, gets United States approval. Semglee, manufactured by Biocon Biologics, a Bengaluru-based pharmaceutical company, is both interchangeable with and biosimilar to Lantus, a long-acting Endocrinology Drugs product already approved in the United States.

Global Endocrinology Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Therapy Area, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy Area:
Diabetes drugs
Thyroid hormone disorders

By Distribution Channel:
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Endocrinology Drugs Market, by Region, 2020-2030 (USD Million)
1.2.2. Endocrinology Drugs Market, by Therapy Area, 2020-2030 (USD Million)
1.2.3. Endocrinology Drugs Market, by Distribution Channel , 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Endocrinology Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Endocrinology Drugs Market Dynamics
3.1. Endocrinology Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Growing clinical trials for development of endocrinology drugs Growing prevalence of endocrine disorder
3.1.2. Market Challenges Expiry of patents
3.1.3. Market Opportunities Advancement in drug development activities Growing aging population
Chapter 4. Global Endocrinology Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Endocrinology Drugs Market, by Therapy Area
5.1. Market Snapshot
5.2. Global Endocrinology Drugs Market by Therapy Area, Performance – Potential Analysis
5.3. Global Endocrinology Drugs Market Estimates & Forecasts by Therapy Area 2020-2030 (USD Million)
5.4. Endocrinology Drugs Market, Sub Segment Analysis
5.4.1. Diabetes drug
5.4.2. HGH
5.4.3. Thyroid hormone disorder
5.4.4. Other
Chapter 6. Global Endocrinology Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Endocrinology Drugs Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Endocrinology Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
6.4. Endocrinology Drugs Market, Sub Segment Analysis
6.4.1. Hospital pharmacies
6.4.2. Retail pharmacies
6.4.3. Online pharmacies
Chapter 7. Global Endocrinology Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Endocrinology Drugs Market, Regional Market Snapshot
7.4. North America Endocrinology Drugs Market
7.4.1. U.S. Endocrinology Drugs Market Therapy Area breakdown estimates & forecasts, 2020-2030 Distribution ChannelChannel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Endocrinology Drugs Market
7.5. Europe Endocrinology Drugs Market Snapshot
7.5.1. U.K. Endocrinology Drugs Market
7.5.2. Germany Endocrinology Drugs Market
7.5.3. France Endocrinology Drugs Market
7.5.4. Spain Endocrinology Drugs Market
7.5.5. Italy Endocrinology Drugs Market
7.5.6. Rest of Europe Endocrinology Drugs Market
7.6. Asia-Pacific Endocrinology Drugs Market Snapshot
7.6.1. China Endocrinology Drugs Market
7.6.2. India Endocrinology Drugs Market
7.6.3. Japan Endocrinology Drugs Market
7.6.4. Australia Endocrinology Drugs Market
7.6.5. South Korea Endocrinology Drugs Market
7.6.6. Rest of Asia Pacific Endocrinology Drugs Market
7.7. Latin America Endocrinology Drugs Market Snapshot
7.7.1. Brazil Endocrinology Drugs Market
7.7.2. Mexico Endocrinology Drugs Market
7.8. Middle East & Africa Endocrinology Drugs Market
7.8.1. Saudi Arabia Endocrinology Drugs Market
7.8.2. South Africa Endocrinology Drugs Market
7.8.3. Rest of Middle East & Africa Endocrinology Drugs Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Acerus Pharmaceuticals corp.
8.3.3. Hanmi Pharm co. Ltd
8.3.4. Oramed Pharmaceuticals
8.3.5. Pfizer Inc.
8.3.6. F. Hoffmann La Roche Ltd.
8.3.7. Glaosmithkline Plc
8.3.8. Biocon Ltd.
8.3.9. Ascendis Pharma AS
8.3.10. Endo Inernational Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now